Explore available resources, including:
Leading experts from around the world have joined together to combine their findings from research and clinical experience to improve outcomes in heart failure.
This truly global curriculum was developed by world-renowned leaders in the management of heart failure and is dedicated to improving guideline-directed care through the dissemination of evidence-based medicine and real-world data. With the education provided here, professionals will be properly equipped to meet the challenges surrounding the use of renin-angiotensin-aldosterone system (RAAS) inhibitor therapies and will understand how to apply emerging science to improve patient outcomes.
This educational series is developed by Medtelligence. Supported by an unrestricted educational grant by Vifor Pharma.